Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Total 13F shares
-
3,289,256
-
Share change
-
-310,935
-
Total reported value
-
$17,267,988
-
Put/Call ratio
-
6.2%
-
Price per share
-
$5.25
-
Number of holders
-
25
-
Value change
-
-$1,696,568
-
Number of buys
-
11
-
Number of sells
-
15
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q2 2024
As of 30 Jun 2024 enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) had 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,289,256 shares of stock of the company.
Largest 10 holders included KINGDON CAPITAL MANAGEMENT, L.L.C., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Nantahala Capital Management, LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), ADAR1 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BlackRock Inc., and Westside Investment Management, Inc..
This table shows 25 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.